AI assistant
ARTIVION, INC. — Director's Dealing 2025
May 12, 2025
31684_dirs_2025-05-12_64620992-b82d-4666-9de5-66cb13d48ccb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ARTIVION, INC. (AORT)
CIK: 0000784199
Period of Report: 2025-05-09
Reporting Person: Stanton Marshall S. (SVP, Clinical & MD Affair)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-09 | Common Stock | S | 5737 | $29.1302 | Disposed | 110143 | Direct |
| 2025-05-09 | Common Stock | S | 4811 | $29.1302 | Disposed | 105332 | Direct |
Footnotes
F1: Reflects weighted average price for Restricted Stock Units. Range of prices were between $28.97 to $29.25. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: Reflects weighted average price for Performance Stock Units. Range of prices were between $28.97 to $29.25. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.